JAK2 and myeloproliferative neoplasm: While NGS confirmed the absence of the JAK2 V617F and exon 12 mutations, several alternative mutations of JAK2 have been identified in sporadic cases of “PV-like” MPN and hereditary erythrocytosis [8–13], yet none were identified by NGS in exons 12–15 in the patient.